BioMed Research International / 2014 / Article / Tab 2

Research Article

Prevalence of Past and Reactivated Viral Infections and Efficacy of Cyclosporine A as Monotherapy or in Combination in Patients with Psoriatic Arthritis—Synergy Study: A Longitudinal Observational Study

Table 2

Description of treatments at baseline and at the end of study.

Baseline (number = 225)From baseline to 12-month followup (number = 174)

Systemic treatments, number (%)
 Cyclosporine110 (48.9)70 (40.2)
 Cyclosporine + methotrexate36 (16.0)26 (14.9)
 Cyclosporine + biologic23 (10.2)38 (21.8)
 Cyclosporine + other systemic treatments45 (20.0)27 (15.5)
 m.d.11 (4.9)13 (7.5)

Topic treatments, no. (%)1
 Total number of patients treated175 (77.8)103 (59.2)
 No topic treatment47 (20.9)68 (39.1)
 m.d.3 (1.3)3 (1.7)
 Corticosteroids157 (69.8)77 (44.3)
 Vit D3 derivatives98 (43.6)53 (30.5)
 Retinoids27 (12.0)8 (4.6)
 PUVA5 (2.2)2 (1.1)
 UVB8 (3.6)4 (2.3)
 Laser1 (0.4)1 (0.6)
 Other15 (6.7)21 (12.1)

Intra-articular injection5 (2.2) 6 (3.4)

Patients might have been treated with more than one topic treatment. m.d.: missing data.